Jeffrey Langsam's most recent trade in Oncology Institute Inc (The) was a trade of 70,270 Common Stock done . Disclosure was reported to the exchange on March 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc | Jeffrey Langsam | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2026 | 70,270 | 127,650 | - | 0 | Common Stock | |
| Oncology Institute Inc | Jeffrey Langsam | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 57,380 | 57,380 | - | 0 | Common Stock |